Lead Product(s) : ProtheraCytes
Therapeutic Area : Cardiology/Vascular Diseases
Sponsor : BioCardia
Deal Size : Undisclosed
Deal Type : Collaboration
CellProthera and BioCardia Collaborate on Phase II ProtheraCytes™ Trial for AMI
Details : The collaboration aims to support the advancement of the mid-stage clinical trial product ProtheraCytes, which is being evaluated for the treatment of acute myocardial infarction led by CellProthera.
Brand Name : ProtheraCytes
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
July 08, 2024
Lead Product(s) : ProtheraCytes
Therapeutic Area : Cardiology/Vascular Diseases
Sponsor : BioCardia
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?